Tag: medicinal cannabis
Medicinal cannabis provider Little Green Pharma receives order to support European trial
Australian medicinal cannabis manufacturer Little Green Pharma (LGP) has received a commercial tender to deliver CBD50 Classic oils to the highly regarded French medicinal cannabis trial 1, the largest government-led European trial.
Medicinal cannabis manufacturer Cannatrek launches new site in Victoria
Australian medicinal company Cannatrek has opened a new manufacturing site in Greater Shepparton after receiving support through the Victorian government’s Regional Jobs Fund.
Cann Group names Peter Koetsier as new CEO
Cann Group, a leading manufacturer and supplier of innovative cannabis medicines, appointed Peter Koetsier as its new chief executive officer, effective 16 January 2023.
Cann Group to reinvest $4.3m R&D tax incentive rebate
Cann Group has received a $4.3 million Research and Development Tax Incentive Rebate for fiscal year 2022
ECS Botanics completes maiden cannabis shipment to the UK
Australian medicinal cannabis and hemp company ECS Botanics has completed its maiden shipment of dried cannabis flower to Lyphe Group, the largest distributor of...
Little Green Pharma unveils plans to manufacture psychedelic medicines in WA
Australian medicinal cannabis producer Little Green Pharma (LGP) has successfully cleared a major hurdle for entering the field of psychedelic medicine with the grant...
ECS Botanics secures a 4-year agreement with MW Pharma Limited
Australian medicinal cannabis and industrial hemp company ECS Botanics has signed a four-year agreement to supply GMP manufactured medicinal cannabis products to MW Pharma...
Cann Group wraps up acquisition of Satipharm
Cann Group Limited (ASX: CAN) has completed the acquisition of the Satipharm business from Harvest One Cannabis Inc. for CAD$4 million, including conditional deferred...
Cann Group supplies medicinal cannabis for Australian clinical trial for advanced cancer patients
Cann Group Limited is supplying medicinal cannabis for Australian clinical trial assessing quality of life impacts for advanced cancer patients.
The trial, which is being...
ECS Botanics’ Murray Meds inks supply agreement with Australian cannabinoid company
ECS Botanics Holdings Ltd (ASX:ECS), through Murray Meds, has entered a three-year agreement with an undisclosed Australian cannabinoid company for the supply of medicinal...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
